Molindone
From Wikipedia, the free encyclopedia
Molindone
|
|
Systematic (IUPAC) name | |
3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)- 1,5,6,7-tetrahydro-4H-indol-4-one |
|
Identifiers | |
CAS number | |
ATC code | N05 |
PubChem | |
Chemical data | |
Formula | C16H24N2O2 |
Mol. mass | 276.374 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | Hepatic |
Half life | 1.5 hours |
Excretion | Minor, renal and fecal |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status | |
Routes | Oral |
Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia.[1] It works by blocking the effects of dopamine in the brain, leading to diminished psychoses. It is rapidly absorbed when taken by mouth.
Molindone is sold under the product name Moban.
[edit] Adverse effects
The side effect profile of molindone is similar to that of other typical antipsychotics. Unlike most antipsychotics, however, molindone use is associated with weight loss.[2][3]
[edit] See also
[edit] References
- ^ molindone (web). F.A. Davis Company. Retrieved on 2007-11-04.
- ^ Bagnall A, Fenton M, Kleijnen J, Lewis R (2007). "Molindone for schizophrenia and severe mental illness". Cochrane Database Syst Rev (1): CD002083. doi: . PMID 17253473.
- ^ Allison DB, Mentore JL, Heo M, et al (1999). "Antipsychotic-induced weight gain: a comprehensive research synthesis". Am J Psychiatry 156 (11): 1686–96. PMID 10553730. Free full text
|